Sorin Group: Change in share capital
Milan, October 15, 2010
Today, the Company has submitted a notice of variation in its share capital, subsequent to the issue of 20,000 (twenty thousand) ordinary shares upon exercise of stock options of the 2006-2011 Plan previously approved during the Shareholders’ Meeting held on May 25, 2006.
The new share capital, fully subscribed and paid up of Euro 470.432.144, is composed of the same number of shares with a par value of 1 Euro each.
For information on the Stock Option Plan please refer to the Information Document published on the Internet site: www.sorin.com.
About the Sorin Group
The Sorin Group (www.sorin.com), is a global medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,600 employees worldwide, the Group focuses on three major therapeutic areas that include: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over 1 million patients are treated with Sorin Group devices in more than 80 countries.
For more information, please visit: www.sorin.com, or contact:
Tel. + 39 02 89011300